Phase 1 Hepatitis B trials recruiting now

All Hepatitis B trials, every phase

Other phases for Hepatitis B

Phase 1 Hepatitis B trials

• A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
  NCT07600788 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 5 locations
• A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
  NCT07200193 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 4 locations
• A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
  NCT07511218 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B
  NCT07771140 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
  NCT06617000 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 7 locations
• A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
  NCT05417932 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 6 locations
• A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults
  NCT07059403 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: Male · 1 location
• A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
  NCT07389044 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
  NCT07024641 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 19 locations
• A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma
  NCT07557251 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection
  NCT07051187 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)
  NCT07741461 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis
  NCT07413549 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients
  NCT06295328 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
  NCT06885710 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• HepB mAb19 in Individuals With Chronic Hepatitis B Infection
  NCT05856890 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
  NCT06680232 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 7 locations
• Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
  NCT06671093 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)
  NCT04745403 · Phase: Phase 1 · Ages: 21 Years to 75 Years · Sex: All (male and female) · 1 location
• SA1211 Injection Phase 1 Study
  NCT07275918 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
  NCT06668727 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection
  NCT07610772 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Study of LW231 in Participants With Chronic Hepatitis B
  NCT07179575 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations
• TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
  NCT04843852 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
  NCT06062966 · Phase: Phase 1 · Ages: 21 Years and older · Sex: All (male and female) · 1 location
• TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
  NCT06513286 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 6 locations
• hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
  NCT03826433 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.